We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.8%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$6.76B
(-2.7%)
Cap. Flow
-$7.92B
Cap. Flow
% of AUM
-3.2%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
3,301
New
48
Increased
1,481
Reduced
1,530
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$508M |
| 2 |
L3Harris
LHX
|
+$420M |
| 3 |
Salesforce
CRM
|
+$251M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$225M |
| 5 |
Texas Instruments
TXN
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$408M |
| 3 |
PayPal
PYPL
|
+$367M |
| 4 |
Qualcomm
QCOM
|
+$306M |
| 5 |
WP
Worldpay, Inc.
WP
|
+$281M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.75% |
| 2 | Financials | 14.53% |
| 3 | Healthcare | 12.29% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Novartis
NVS
$297B
| $1.12M | ﹤0.01% |
12,860
+437
| +4% | +$39.2K |
|
|
SYRS
2652
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.12M | ﹤0.01% |
10,764
-436
| -4% | -$41.2K |
|
|
KDMN
2653
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.11M | ﹤0.01% |
442,352
-145,764
| -25% | -$362K |
|
2654
Cyclerion Therapeutics
CYCN
$16.7M
| $1.11M | ﹤0.01% |
4,592
-1,262
| -22% | -$273K |
|
2655
Syndax Pharmaceuticals
SNDX
$1.82B
| $1.11M | ﹤0.01% |
148,988
+39,756
| +36% | +$362K |
|
2656
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $1.11M | ﹤0.01% |
39,805
-2,595
| -6% | -$73.4K |
|
2657
Lifecore Biomedical
LFCR
$190M
| $1.11M | ﹤0.01% |
101,886
+2,368
| +2% | +$25.8K |
|
|
JCP
2658
DELISTED
J.C. Penney Company, Inc.
JCP
| $1.1M | ﹤0.01% |
1,243,450
-11,970
| -1% | -$10.1K |
|
2659
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $1.1M | ﹤0.01% |
46,216
+1,961
| +4% | +$47.1K |
|
|
EBTC
2660
DELISTED
Enterprise Bancorp
EBTC
| $1.1M | ﹤0.01% |
36,664
+688
| +2% | +$20.3K |
|
2661
Nordic American Tanker
NAT
$1.37B
| $1.1M | ﹤0.01% |
507,957
-227,238
| -31% | -$458K |
|
|
IVC
2662
DELISTED
Invacare Corporation
IVC
| $1.09M | ﹤0.01% |
146,051
-7,338
| -5% | -$41.2K |
|
|
LEO
2663
BNY Mellon Strategic Municipals
LEO
$387M
| $1.09M | ﹤0.01% |
127,525
| – | – |
|
2664
PAR Technology
PAR
$735M
| $1.09M | ﹤0.01% |
45,700
-2,507
| -5% | -$61.1K |
|
2665
UroGen Pharma
URGN
$2.29B
| $1.08M | ﹤0.01% |
45,444
+2,618
| +6% | +$85.6K |
|
2666
Southern First Bancshares
SFST
$600M
| $1.08M | ﹤0.01% |
27,164
-1,655
| -6% | -$64.3K |
|
|
ADMS
2667
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.08M | ﹤0.01% |
211,479
+107,456
| +103% | +$663K |
|
2668
Hooker Furnishings Corp
HOFT
$166M
| $1.08M | ﹤0.01% |
50,207
+3,576
| +8% | +$71.9K |
|
|
FRTA
2669
DELISTED
Forterra, Inc
FRTA
| $1.07M | ﹤0.01% |
148,772
+14,204
| +11% | +$91.6K |
|
|
DERM
2670
DELISTED
Dermira, Inc.
DERM
| $1.07M | ﹤0.01% |
168,108
-8,335
| -5% | -$69.6K |
|
2671
Teekay
TK
$985M
| $1.07M | ﹤0.01% |
268,264
-12,660
| -5% | -$50.7K |
|
2672
Daily Journal
DJCO
$778M
| $1.07M | ﹤0.01% |
4,330
+237
| +6% | +$53.9K |
|
|
DVAX
2673
DELISTED
Dynavax Technologies
DVAX
| $1.07M | ﹤0.01% |
299,855
+56,971
| +23% | +$221K |
|
|
FRGI
2674
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $1.07M | ﹤0.01% |
102,610
-4,737
| -4% | -$49.5K |
|
|
XXII
2675
22nd Century Group
XXII
$1.48M
| – | – |
0
| – | – |
|
Similar funds
VFT
Nuveen's Q3 2019 Portfolio in Review
As of Q3 2019, Nuveen held 3,301 positions worth $247B, down 2.7% from $254B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Nuveen withdrew a net $7.92B in Q3 2019, closing 86 positions and reducing 1,530 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Nuveen opened a new position in Medallia, Inc. worth $97.7M.
- Nuveen's largest Q3 2019 buy was Medallia, Inc.: 3,562,327 shares worth $97.7M.
- Nuveen added most to Fidelity National Information Services in Q3 2019, an estimated $508M increase.
- Nuveen's biggest Q3 2019 reduction was Microsoft, cutting an estimated $408M.
- Nuveen fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2019, selling an estimated $1.13B.
- Nuveen's ten largest holdings make up 18% of its $247B portfolio in Q3 2019.
- Nuveen opened 48 new positions and closed 86 in Q3 2019.
- Nuveen's portfolio value fell 2.7% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2019, filed 14 Nov 2019.